India’s apex drug regulator has allowed Pune-based Serum Institute of India to conduct late-stage — Phase 2 and 3 — human trials in India for the Oxford University Covid-19 vaccine candidate.
from Times of India https://ift.tt/39ZeN7J
Monday 3 August 2020
Subscribe to:
Post Comments (Atom)
Bollywood News And Much More In Gujarati Language. Gujarati Literature. Excellent Coverage. Premium Content. Most Accurate
No comments:
Post a Comment